Omura Masao, Saito Jun, Yamaguchi Kunio, Kakuta Yukio, Nishikawa Tetsuo
Department of Medicine, Yokohama Rosai Hospital, Yokohama, Japan.
Hypertens Res. 2004 Mar;27(3):193-202. doi: 10.1291/hypres.27.193.
Secondary hypertension (SH) including endocrine hypertension has been reported to be uncommon. We estimated the prevalence of SH among hypertensive patients. We prospectively studied 1,020 hypertensive patients. As an initial screening, we measured plasma aldosterone concentration, plasma renin activity, serum cortisol concentration and plasma catecholamine concentration and conducted abdominal ultrasonography (US). As a secondary screening, we performed furosemide plus upright test, captopril renography, dexamethasone suppression test, 24-h urine catecholamine measurement and abdominal CT. Finally, primary aldosteronism with the exception of idiopathic hyperaldosteronism, pheochromocytoma, and Cushing's syndrome were diagnosed by histopathological examination of surgical specimens. Idiopathic hyperaldosteronism was clinically diagnosed by adrenocorticotrophic hormone (ACTH)-stimulated adrenal venous sampling and renovascular hypertension by renal arteriography. There were 61 patients with primary aldosteronism, 5 with renovascular hypertension, 11 with Cushing's syndrome, 10 with preclinical Cushing's syndrome and 6 with pheochromocytoma, and the prevalence of SH was 9.1% among 1,020 hypertensive patients. In 76 (82%) of 93 patients with SH, hypertension was cured or improved after unilateral adrenalectomy, transsphenoidal pituitary adenectomy or percutaneous transluminal angioplasty. With the exception of US and CT, all initial and secondary screening tests were found to be sensitive and specific for differentiating SH from essential hypertension (EH). In conclusion, the measurement of various hormone concentrations was very sensitive for ruling out SH--a condition for which, in the present study, there were few specific signs or symptoms--while CT and US examinations were not always useful for differentiating SH from EH. The prevalence of curable SH among hypertensive subjects was higher in this study, which was conducted by our simple method of screening tests, than in previous reports. Hypertensive patients should be screened for SH and the underlying disease treated appropriately to avoid long-term use of antihypertensive drugs and risks of atherosclerotic complications.
据报道,包括内分泌性高血压在内的继发性高血压(SH)并不常见。我们估算了高血压患者中SH的患病率。我们对1020例高血压患者进行了前瞻性研究。作为初始筛查,我们检测了血浆醛固酮浓度、血浆肾素活性、血清皮质醇浓度和血浆儿茶酚胺浓度,并进行了腹部超声检查(US)。作为二次筛查,我们进行了速尿加立位试验、卡托普利肾图检查、地塞米松抑制试验、24小时尿儿茶酚胺测定和腹部CT检查。最后,通过手术标本的组织病理学检查诊断出除特发性醛固酮增多症外的原发性醛固酮增多症、嗜铬细胞瘤和库欣综合征。特发性醛固酮增多症通过促肾上腺皮质激素(ACTH)刺激的肾上腺静脉采血进行临床诊断,肾血管性高血压通过肾动脉造影进行诊断。有61例原发性醛固酮增多症患者、5例肾血管性高血压患者、11例库欣综合征患者、10例临床前库欣综合征患者和6例嗜铬细胞瘤患者,在1020例高血压患者中SH的患病率为9.1%。在93例SH患者中的76例(82%),经单侧肾上腺切除术、经蝶窦垂体腺瘤切除术或经皮腔内血管成形术后,高血压得到治愈或改善。除US和CT外,所有初始和二次筛查试验对于区分SH和原发性高血压(EH)均具有敏感性和特异性。总之,各种激素浓度检测对于排除SH非常敏感,在本研究中SH几乎没有特异性体征或症状,而CT和US检查对于区分SH和EH并不总是有用。通过我们简单的筛查试验方法进行的这项研究中,高血压患者中可治愈的SH患病率高于既往报道。高血压患者应筛查SH并对潜在疾病进行适当治疗,以避免长期使用降压药物及动脉粥样硬化并发症的风险。